Search

Your search keyword '"Al Bakir, M"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Al Bakir, M" Remove constraint Author: "Al Bakir, M" Search Limiters Full Text Remove constraint Search Limiters: Full Text
41 results on '"Al Bakir, M"'

Search Results

1. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

2. Genomic–transcriptomic evolution in lung cancer and metastasis

3. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

4. The evolution of lung cancer and impact of subclonal selection in TRACERx

5. Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

7. The evolution of lung cancer and impact of subclonal selection in TRACERx

8. A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

9. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

10. 889P Development of a head and neck immune prognostic index (HN-IPI) classification for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) who received immune checkpoint inhibitors (ICIs)

11. Using DNA sequencing data to quantify T cell fraction and therapy response

13. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

14. The T cell differentiation landscape is shaped by tumour mutations in lung cancer

15. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

16. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

17. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

18. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution

19. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

21. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

22. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

23. Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapy.

24. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

25. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.

26. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.

27. The evolution of non-small cell lung cancer metastases in TRACERx.

28. The evolution of lung cancer and impact of subclonal selection in TRACERx.

29. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

30. Genomic-transcriptomic evolution in lung cancer and metastasis.

31. Lung adenocarcinoma promotion by air pollutants.

32. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.

33. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.

34. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.

35. Publisher Correction: A clonal expression biomarker associates with lung cancer mortality.

36. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.

37. Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.

38. Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.

39. A clonal expression biomarker associates with lung cancer mortality.

40. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

41. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Catalog

Books, media, physical & digital resources